DARU-Journal of Pharmaceutical Sciences

Papers
(The H4-Index of DARU-Journal of Pharmaceutical Sciences is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Solid dispersion technology as a formulation strategy for the fabrication of modified release dosage forms: A comprehensive review36
Zinc-containing Mohs’ paste affects blood flow and angiogenesis suppression32
Characteristics of published/registered clinical trials on COVID-19 treatment: A systematic review29
Calcineurin inhibitors and related medicines: a cohort study examining England’s primary care prescription changes during the COVID-19 pandemic (January 2019 to March 2021)23
Novel biodegradable molecularly imprinted polymer nanoparticles for drug delivery of methotrexate anti-cancer; synthesis, characterization and cellular studies20
Designing and psychometric evaluation of pharmacists' attitude toward ethical challenges questionnaire in pharmacy practice: A mixed‑method study17
Alpinumisoflavone against cancer pro-angiogenic targets: In silico, In vitro, and In ovo evaluation17
Developing an AI-based prediction model for anaphylactic shock from injection drugs using Japanese real-world data and chemical structure-based analysis15
Evaluating the effect of sodium alginate and sodium carboxymethylcellulose on pulmonary delivery of levofloxacin spray-dried microparticles14
Fruit vinegar as a promising source of natural anti-inflammatory agents: an up-to-date review13
Evaluation of time-to-onset and outcome of cardiac adverse events related to pembrolizumab using post-marketing surveillance in Japanese patients13
In-vivo and in-vitro assessment of curcumin loaded bile salt stabilized nanovesicles for oral delivery12
The association between anti-diabetic agents and osteoporosis, sarcopenia, and osteosarcopenia among Iranian older adults; Bushehr Elderly Health (BEH) program12
Dry powder inhaler design and particle technology in enhancing Pulmonary drug deposition: challenges and future strategies12
0.060229063034058